A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors
针对过渡态和突变型表皮生长因子受体的单克隆抗体 ch806 的 I 期临床试验
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:
doi:10.1073/pnas.0611693104
Andrew M Scott, Fook-Thean Lee, Niall Tebbutt, Rebecca Herbertson, Sanjeev S Gill, Zhanqi Liu, Effie Skrinos, Carmel Murone, Timothy H Saunder, Bridget Chappell, Anthony T Papenfuss, Aurora M T Poon, Wendie Hopkins, Fiona E Smyth, Duncan MacGregor, Lawrence M Cher, Achim A Jungbluth, Gerd Ritter, Ma
